Pathways’ Picks September 16: FDA’s Post-COVID Planning, New Notified Body, and More

article image

In this week’s roundup: CDRH Post-COVID transition planning draft guidance is in the works, Pre-Subs are suffering, Slovakia has its first MDR notified body, Brazil seeks feedback on plans for new software rules, and more.

FDA’s device center is preparing a draft guidance on its plan for eventually transitioning regulatory operations away from a COVID-19 emergency footing, even as officials stress that responding to the pandemic will remain the agency’s top priority for the foreseeable future. That and more FDA updates lead off this week’s Pathways’ Picks. Also: a global news roundup.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to Market Pathways:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to Market Pathways
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: